{
    "medicine_id": "be635ad38b656197ad324eec53c580239a040dd6",
    "platform_id": "DB00807",
    "metadata": {
        "name": "Alcaine 5 mg 1mL Solution drops",
        "composition": "5 mg 1mL Proparacaine",
        "clinical_particulars": {
            "therapeutic_indications": "Used as a local ophthalmic anesthetic",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Proparacaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action More specifically proparacaine appears to bind or antagonize the function of voltage gated sodium channels",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00070",
                        "description": "Hyaluronidase ovine can cause an increase in the absorption of Proparacaine resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB06205",
                        "description": "Hyaluronidase human recombinant can cause an increase in the absorption of Proparacaine resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB14740",
                        "description": "Hyaluronidase can cause an increase in the absorption of Proparacaine resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}